| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 55 | 2022 | 1494 | 2.530 |
Why?
|
| Premature Birth | 12 | 2022 | 137 | 1.880 |
Why?
|
| Intrauterine Devices | 6 | 2022 | 11 | 1.780 |
Why?
|
| Stillbirth | 7 | 2020 | 29 | 1.680 |
Why?
|
| Female | 78 | 2023 | 12608 | 1.640 |
Why?
|
| Pregnancy, Ectopic | 2 | 2022 | 6 | 1.610 |
Why?
|
| Pregnancy Complications | 7 | 2014 | 196 | 1.590 |
Why?
|
| Humans | 87 | 2023 | 17611 | 1.520 |
Why?
|
| Transgender Persons | 8 | 2023 | 38 | 1.370 |
Why?
|
| Retrospective Studies | 33 | 2022 | 2447 | 1.340 |
Why?
|
| Infant Mortality | 6 | 2020 | 20 | 1.300 |
Why?
|
| Pregnancy Outcome | 9 | 2020 | 154 | 1.290 |
Why?
|
| Gestational Age | 10 | 2020 | 111 | 1.230 |
Why?
|
| Adult | 48 | 2022 | 7598 | 1.210 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2020 | 64 | 1.120 |
Why?
|
| Diabetes, Gestational | 5 | 2021 | 340 | 1.110 |
Why?
|
| Autism Spectrum Disorder | 4 | 2022 | 163 | 1.100 |
Why?
|
| Fetal Membranes, Premature Rupture | 6 | 2016 | 11 | 1.060 |
Why?
|
| Cohort Studies | 28 | 2022 | 2570 | 1.050 |
Why?
|
| Abruptio Placentae | 9 | 2007 | 10 | 1.040 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2020 | 136 | 1.010 |
Why?
|
| Infant, Newborn | 20 | 2020 | 844 | 1.000 |
Why?
|
| Cesarean Section | 4 | 2013 | 30 | 1.000 |
Why?
|
| Risk Factors | 28 | 2022 | 3325 | 0.990 |
Why?
|
| Chorioamnionitis | 3 | 2015 | 18 | 0.940 |
Why?
|
| California | 18 | 2021 | 2284 | 0.930 |
Why?
|
| Young Adult | 24 | 2023 | 2427 | 0.920 |
Why?
|
| Pre-Eclampsia | 3 | 2017 | 40 | 0.890 |
Why?
|
| Body Mass Index | 9 | 2015 | 958 | 0.890 |
Why?
|
| Incidence | 12 | 2022 | 1255 | 0.890 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2020 | 160 | 0.780 |
Why?
|
| European Continental Ancestry Group | 7 | 2010 | 529 | 0.770 |
Why?
|
| Male | 32 | 2023 | 10008 | 0.750 |
Why?
|
| Adolescent | 30 | 2023 | 3651 | 0.750 |
Why?
|
| Child | 21 | 2022 | 2474 | 0.740 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 56 | 0.730 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 16 | 0.720 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 10 | 0.720 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2020 | 41 | 0.710 |
Why?
|
| Infant | 13 | 2022 | 1171 | 0.710 |
Why?
|
| Infant, Premature | 5 | 2022 | 60 | 0.700 |
Why?
|
| Patient Admission | 1 | 2020 | 72 | 0.700 |
Why?
|
| Child, Preschool | 15 | 2022 | 1409 | 0.690 |
Why?
|
| Prevalence | 15 | 2023 | 884 | 0.670 |
Why?
|
| African Americans | 7 | 2020 | 472 | 0.670 |
Why?
|
| Length of Stay | 1 | 2020 | 181 | 0.670 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 49 | 0.670 |
Why?
|
| Maternal Age | 7 | 2020 | 77 | 0.660 |
Why?
|
| Pregnancy in Diabetics | 2 | 2018 | 21 | 0.650 |
Why?
|
| Asthma | 3 | 2022 | 385 | 0.640 |
Why?
|
| Parity | 5 | 2020 | 74 | 0.610 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2015 | 34 | 0.610 |
Why?
|
| United States | 20 | 2022 | 3956 | 0.610 |
Why?
|
| Pandemics | 1 | 2020 | 287 | 0.600 |
Why?
|
| Uterine Perforation | 3 | 2022 | 3 | 0.600 |
Why?
|
| Risk | 5 | 2016 | 516 | 0.590 |
Why?
|
| Labor, Induced | 2 | 2014 | 6 | 0.590 |
Why?
|
| Respiration Disorders | 2 | 2007 | 5 | 0.580 |
Why?
|
| Asphyxia | 1 | 2017 | 3 | 0.570 |
Why?
|
| Obstetric Labor Complications | 1 | 2017 | 13 | 0.570 |
Why?
|
| Placenta | 4 | 2019 | 20 | 0.560 |
Why?
|
| Siblings | 1 | 2016 | 12 | 0.550 |
Why?
|
| Infant, Small for Gestational Age | 5 | 2022 | 57 | 0.530 |
Why?
|
| Risk Assessment | 9 | 2022 | 1097 | 0.510 |
Why?
|
| Ethnic Groups | 4 | 2014 | 485 | 0.500 |
Why?
|
| Sepsis | 1 | 2015 | 70 | 0.480 |
Why?
|
| Twins | 1 | 2014 | 12 | 0.470 |
Why?
|
| Sudden Infant Death | 2 | 2004 | 10 | 0.470 |
Why?
|
| Benzhydryl Compounds | 3 | 2019 | 23 | 0.470 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 9 | 0.470 |
Why?
|
| Crohn Disease | 1 | 2014 | 14 | 0.460 |
Why?
|
| Phenols | 3 | 2019 | 34 | 0.460 |
Why?
|
| Hospitalization | 6 | 2020 | 797 | 0.450 |
Why?
|
| Prenatal Care | 4 | 2015 | 128 | 0.450 |
Why?
|
| Pyelonephritis | 1 | 2013 | 3 | 0.450 |
Why?
|
| Autistic Disorder | 1 | 2015 | 100 | 0.450 |
Why?
|
| Pregnancy, Multiple | 2 | 2020 | 4 | 0.450 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 140 | 0.450 |
Why?
|
| Logistic Models | 12 | 2021 | 926 | 0.440 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2012 | 7 | 0.430 |
Why?
|
| Intrauterine Devices, Copper | 2 | 2022 | 5 | 0.420 |
Why?
|
| Transsexualism | 3 | 2023 | 10 | 0.420 |
Why?
|
| Intrauterine Devices, Medicated | 2 | 2022 | 4 | 0.420 |
Why?
|
| Diseases in Twins | 3 | 2009 | 15 | 0.390 |
Why?
|
| Vaccination | 5 | 2022 | 635 | 0.380 |
Why?
|
| Acne Vulgaris | 2 | 2021 | 8 | 0.360 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2022 | 107 | 0.360 |
Why?
|
| Case-Control Studies | 8 | 2020 | 1115 | 0.340 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 2 | 2020 | 86 | 0.340 |
Why?
|
| Breast Feeding | 2 | 2022 | 133 | 0.340 |
Why?
|
| Cross-Sectional Studies | 7 | 2022 | 1322 | 0.340 |
Why?
|
| African Continental Ancestry Group | 2 | 2007 | 162 | 0.330 |
Why?
|
| Fetal Death | 2 | 2008 | 9 | 0.330 |
Why?
|
| Postpartum Period | 4 | 2022 | 94 | 0.330 |
Why?
|
| Cytokines | 2 | 2019 | 30 | 0.330 |
Why?
|
| Middle Aged | 16 | 2022 | 7911 | 0.320 |
Why?
|
| Mental Disorders | 2 | 2023 | 280 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 748 | 0.320 |
Why?
|
| Obesity | 6 | 2010 | 837 | 0.310 |
Why?
|
| Smoking | 3 | 2008 | 483 | 0.300 |
Why?
|
| Gravidity | 1 | 2007 | 8 | 0.300 |
Why?
|
| Longitudinal Studies | 6 | 2018 | 710 | 0.300 |
Why?
|
| Halogenated Diphenyl Ethers | 2 | 2019 | 8 | 0.290 |
Why?
|
| Influenza Vaccines | 2 | 2020 | 267 | 0.290 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 709 | 0.290 |
Why?
|
| Fetal Macrosomia | 1 | 2007 | 26 | 0.290 |
Why?
|
| Environmental Pollutants | 2 | 2019 | 46 | 0.290 |
Why?
|
| Income | 2 | 2020 | 90 | 0.280 |
Why?
|
| Triplets | 1 | 2006 | 2 | 0.270 |
Why?
|
| Natural Childbirth | 1 | 2006 | 1 | 0.270 |
Why?
|
| Placenta Previa | 1 | 2006 | 3 | 0.270 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2021 | 531 | 0.270 |
Why?
|
| Health Status | 4 | 2022 | 298 | 0.270 |
Why?
|
| Medical Records | 3 | 2018 | 100 | 0.260 |
Why?
|
| Weight Gain | 1 | 2007 | 173 | 0.260 |
Why?
|
| Missouri | 5 | 2008 | 9 | 0.260 |
Why?
|
| Maternal Behavior | 2 | 2008 | 13 | 0.250 |
Why?
|
| Family Characteristics | 1 | 2005 | 54 | 0.250 |
Why?
|
| Acute Disease | 3 | 2013 | 142 | 0.240 |
Why?
|
| Self-Injurious Behavior | 2 | 2023 | 44 | 0.240 |
Why?
|
| Recurrence | 6 | 2010 | 186 | 0.240 |
Why?
|
| Perinatal Care | 1 | 2004 | 12 | 0.230 |
Why?
|
| Elective Surgical Procedures | 2 | 2014 | 8 | 0.230 |
Why?
|
| Gender Identity | 5 | 2023 | 36 | 0.230 |
Why?
|
| Age Distribution | 3 | 2013 | 246 | 0.230 |
Why?
|
| Odds Ratio | 6 | 2010 | 671 | 0.220 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 1210 | 0.220 |
Why?
|
| Hispanic Americans | 3 | 2010 | 404 | 0.220 |
Why?
|
| Age Factors | 5 | 2013 | 917 | 0.220 |
Why?
|
| Registries | 2 | 2020 | 471 | 0.210 |
Why?
|
| Menorrhagia | 1 | 2022 | 3 | 0.210 |
Why?
|
| Escherichia coli | 2 | 2019 | 6 | 0.210 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2022 | 3 | 0.210 |
Why?
|
| Sexual and Gender Minorities | 1 | 2023 | 27 | 0.210 |
Why?
|
| Eczema | 1 | 2022 | 7 | 0.210 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2022 | 6 | 0.210 |
Why?
|
| Hormones | 1 | 2022 | 14 | 0.210 |
Why?
|
| Contraceptive Agents, Female | 1 | 2022 | 12 | 0.200 |
Why?
|
| Intrauterine Device Expulsion | 4 | 2022 | 5 | 0.200 |
Why?
|
| Immunologic Factors | 1 | 2022 | 27 | 0.200 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2021 | 12 | 0.200 |
Why?
|
| Birth Certificates | 2 | 2012 | 22 | 0.200 |
Why?
|
| Seizures, Febrile | 1 | 2022 | 42 | 0.200 |
Why?
|
| Measles | 1 | 2022 | 24 | 0.190 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2021 | 15 | 0.190 |
Why?
|
| Contraception | 1 | 2021 | 25 | 0.190 |
Why?
|
| Prescriptions | 1 | 2021 | 27 | 0.190 |
Why?
|
| Research Design | 2 | 2021 | 374 | 0.190 |
Why?
|
| Continental Population Groups | 3 | 2013 | 302 | 0.190 |
Why?
|
| Uveal Neoplasms | 1 | 2021 | 3 | 0.190 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 5 | 0.190 |
Why?
|
| Eye Diseases | 1 | 2021 | 6 | 0.190 |
Why?
|
| Testosterone | 1 | 2021 | 22 | 0.190 |
Why?
|
| Whooping Cough | 1 | 2022 | 66 | 0.190 |
Why?
|
| Delivery of Health Care | 3 | 2022 | 415 | 0.190 |
Why?
|
| Air Pollutants | 1 | 2021 | 52 | 0.190 |
Why?
|
| Air Pollution | 1 | 2021 | 42 | 0.190 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 20 | 0.180 |
Why?
|
| Database Management Systems | 1 | 2020 | 14 | 0.180 |
Why?
|
| Vaccination Coverage | 1 | 2021 | 41 | 0.180 |
Why?
|
| Pregnant Women | 1 | 2021 | 45 | 0.180 |
Why?
|
| Cardiology | 1 | 2021 | 30 | 0.180 |
Why?
|
| American Heart Association | 1 | 2021 | 49 | 0.180 |
Why?
|
| Melanoma | 1 | 2021 | 35 | 0.180 |
Why?
|
| Inflammation | 2 | 2019 | 62 | 0.180 |
Why?
|
| Asymptomatic Infections | 1 | 2020 | 5 | 0.180 |
Why?
|
| Bursitis | 1 | 2020 | 4 | 0.180 |
Why?
|
| Shoulder Joint | 1 | 2020 | 5 | 0.180 |
Why?
|
| Validation Studies as Topic | 1 | 2020 | 11 | 0.180 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2021 | 42 | 0.180 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 35 | 0.180 |
Why?
|
| Term Birth | 3 | 2015 | 8 | 0.170 |
Why?
|
| Betacoronavirus | 1 | 2020 | 35 | 0.170 |
Why?
|
| Polybrominated Biphenyls | 1 | 2019 | 1 | 0.170 |
Why?
|
| Exosomes | 1 | 2019 | 2 | 0.170 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 4 | 0.170 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2019 | 5 | 0.170 |
Why?
|
| Hepatitis A | 1 | 2019 | 10 | 0.170 |
Why?
|
| Hepatitis A Vaccines | 1 | 2019 | 14 | 0.170 |
Why?
|
| Environmental Exposure | 2 | 2021 | 116 | 0.170 |
Why?
|
| Vaccines | 1 | 2022 | 212 | 0.170 |
Why?
|
| Fetal Growth Retardation | 3 | 2009 | 11 | 0.170 |
Why?
|
| Suicide, Attempted | 1 | 2020 | 96 | 0.170 |
Why?
|
| Sex Distribution | 2 | 2013 | 190 | 0.170 |
Why?
|
| Blood Pressure | 1 | 2021 | 298 | 0.160 |
Why?
|
| Asian Americans | 2 | 2010 | 176 | 0.160 |
Why?
|
| Trialkyltin Compounds | 1 | 2018 | 1 | 0.160 |
Why?
|
| Medicaid | 1 | 2020 | 186 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 318 | 0.160 |
Why?
|
| Sex Factors | 3 | 2016 | 643 | 0.150 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 43 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2020 | 163 | 0.150 |
Why?
|
| Sex Reassignment Surgery | 1 | 2017 | 2 | 0.150 |
Why?
|
| Chronic Disease | 4 | 2009 | 428 | 0.140 |
Why?
|
| Mothers | 2 | 2018 | 105 | 0.140 |
Why?
|
| Apgar Score | 1 | 2017 | 5 | 0.140 |
Why?
|
| Educational Status | 2 | 2015 | 200 | 0.140 |
Why?
|
| Uterine Hemorrhage | 2 | 2007 | 9 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2021 | 309 | 0.130 |
Why?
|
| Body Height | 3 | 2010 | 62 | 0.130 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 6 | 0.130 |
Why?
|
| Parturition | 1 | 2015 | 9 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 14 | 0.130 |
Why?
|
| Streptococcal Infections | 1 | 2015 | 22 | 0.130 |
Why?
|
| Mental Health | 3 | 2023 | 165 | 0.120 |
Why?
|
| Overweight | 2 | 2007 | 269 | 0.120 |
Why?
|
| Pregnancy Trimesters | 1 | 2015 | 30 | 0.120 |
Why?
|
| Flame Retardants | 1 | 2014 | 11 | 0.120 |
Why?
|
| Body Weight | 3 | 2010 | 219 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2007 | 568 | 0.120 |
Why?
|
| Electronic Health Records | 3 | 2021 | 681 | 0.120 |
Why?
|
| Fever | 2 | 2022 | 55 | 0.120 |
Why?
|
| Global Health | 1 | 2014 | 33 | 0.120 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 454 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2013 | 297 | 0.120 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 268 | 0.120 |
Why?
|
| Maternal Exposure | 1 | 2014 | 60 | 0.120 |
Why?
|
| Levonorgestrel | 2 | 2022 | 5 | 0.100 |
Why?
|
| Confidence Intervals | 3 | 2010 | 237 | 0.100 |
Why?
|
| Demography | 2 | 2022 | 101 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2012 | 86 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2022 | 70 | 0.090 |
Why?
|
| Insurance, Health | 1 | 2012 | 181 | 0.090 |
Why?
|
| Umbilical Cord | 2 | 2007 | 4 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 85 | 0.090 |
Why?
|
| Fetal Diseases | 1 | 2010 | 8 | 0.090 |
Why?
|
| Obstetric Labor, Premature | 2 | 2007 | 9 | 0.090 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 79 | 0.090 |
Why?
|
| Fetal Distress | 1 | 2009 | 4 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2009 | 6 | 0.080 |
Why?
|
| Suicidal Ideation | 2 | 2020 | 100 | 0.080 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 9 | 0.070 |
Why?
|
| Pneumonia, Bacterial | 1 | 2007 | 7 | 0.070 |
Why?
|
| Confounding Factors (Epidemiology) | 2 | 2006 | 86 | 0.070 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2007 | 1 | 0.070 |
Why?
|
| Betaine-Homocysteine S-Methyltransferase | 1 | 2007 | 1 | 0.070 |
Why?
|
| Congenital Abnormalities | 1 | 2007 | 26 | 0.070 |
Why?
|
| Aged | 3 | 2021 | 6095 | 0.070 |
Why?
|
| Health Surveys | 1 | 2008 | 260 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2007 | 53 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 62 | 0.070 |
Why?
|
| Causality | 2 | 2022 | 40 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 1 | 2006 | 5 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 1267 | 0.070 |
Why?
|
| Cesarean Section, Repeat | 1 | 2006 | 2 | 0.070 |
Why?
|
| Live Birth | 1 | 2006 | 9 | 0.070 |
Why?
|
| Probability | 1 | 2006 | 79 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 373 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2008 | 630 | 0.060 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2005 | 10 | 0.060 |
Why?
|
| Sick Leave | 1 | 2005 | 8 | 0.060 |
Why?
|
| Hypoglycemia | 1 | 2005 | 46 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2005 | 92 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2005 | 114 | 0.060 |
Why?
|
| Health Expenditures | 1 | 2005 | 75 | 0.060 |
Why?
|
| Dysmenorrhea | 1 | 2022 | 3 | 0.050 |
Why?
|
| Sexual Development | 1 | 2022 | 4 | 0.050 |
Why?
|
| Aluminum | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hypertension | 1 | 2007 | 500 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2022 | 45 | 0.050 |
Why?
|
| Measles Vaccine | 1 | 2022 | 17 | 0.050 |
Why?
|
| Bias | 1 | 2022 | 102 | 0.050 |
Why?
|
| Nitrogen Dioxide | 1 | 2021 | 13 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2022 | 80 | 0.050 |
Why?
|
| Patient Safety | 1 | 2022 | 39 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2021 | 29 | 0.050 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2022 | 62 | 0.050 |
Why?
|
| Chickenpox Vaccine | 1 | 2022 | 91 | 0.050 |
Why?
|
| Uveitis | 1 | 2021 | 8 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2021 | 43 | 0.050 |
Why?
|
| Deltoid Muscle | 1 | 2020 | 4 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2020 | 10 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 351 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2019 | 3 | 0.040 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2019 | 3 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2019 | 10 | 0.040 |
Why?
|
| Air Pollutants, Occupational | 1 | 2019 | 16 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 42 | 0.040 |
Why?
|
| Data Collection | 1 | 2020 | 256 | 0.040 |
Why?
|
| Anxiety | 1 | 2020 | 150 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2018 | 1 | 0.040 |
Why?
|
| Biomarkers | 1 | 2019 | 301 | 0.040 |
Why?
|
| Georgia | 1 | 2018 | 26 | 0.040 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2018 | 10 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2018 | 42 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 330 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 77 | 0.040 |
Why?
|
| Time Factors | 1 | 2021 | 1086 | 0.040 |
Why?
|
| Homocysteine | 2 | 2007 | 13 | 0.040 |
Why?
|
| Vitamin B 12 | 2 | 2007 | 15 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 91 | 0.040 |
Why?
|
| Folic Acid | 2 | 2007 | 32 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 121 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 93 | 0.040 |
Why?
|
| Genotype | 2 | 2007 | 227 | 0.040 |
Why?
|
| Quality of Life | 1 | 2020 | 507 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 2016 | 1 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2018 | 222 | 0.030 |
Why?
|
| Depression | 1 | 2020 | 502 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 231 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 1900 | 0.030 |
Why?
|
| Perineum | 1 | 2013 | 2 | 0.030 |
Why?
|
| Perinatal Mortality | 1 | 2013 | 4 | 0.030 |
Why?
|
| Health Planning | 1 | 2010 | 16 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 45 | 0.020 |
Why?
|
| Prepaid Health Plans | 1 | 2010 | 20 | 0.020 |
Why?
|
| Catchment Area (Health) | 1 | 2010 | 8 | 0.020 |
Why?
|
| Hepatitis | 1 | 2009 | 5 | 0.020 |
Why?
|
| Environment | 1 | 2009 | 51 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 35 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 201 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 45 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2007 | 4 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 30 | 0.020 |
Why?
|
| DNA | 1 | 2007 | 22 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 49 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 154 | 0.020 |
Why?
|
| Alleles | 1 | 2007 | 84 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 43 | 0.020 |
Why?
|
| Social Class | 1 | 2007 | 120 | 0.020 |
Why?
|
| Decidua | 1 | 2006 | 1 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 594 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 368 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 375 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 487 | 0.010 |
Why?
|